Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.

Kirchgesner J, Nyboe Andersen N, Carrat F, Jess T, Beaugerie L; BERENICE study group.

Gut. 2019 Aug 24. pii: gutjnl-2019-318932. doi: 10.1136/gutjnl-2019-318932. [Epub ahead of print]

PMID:
31446428
2.

Clinical and economic burden of head and neck cancer: a nationwide retrospective cohort study from France.

Schernberg A, Sagaon-Teyssier L, Schwarzinger M.

Clinicoecon Outcomes Res. 2019 Jul 22;11:441-451. doi: 10.2147/CEOR.S198312. eCollection 2019.

3.

Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer.

Schwarzinger M, Luchini S; EPICORL Study Group.

Health Qual Life Outcomes. 2019 Jul 25;17(1):129. doi: 10.1186/s12955-019-1195-9.

4.

Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage.

Cossais S, Schwarzinger M, Pol S, Fontaine H, Larrey D, Pageaux GP, Canva V, Mathurin P, Yazdanpanah Y, Deuffic-Burban S.

PLoS One. 2019 May 3;14(5):e0215596. doi: 10.1371/journal.pone.0215596. eCollection 2019.

5.

Alcohol use and dementia: a systematic scoping review.

Rehm J, Hasan OSM, Black SE, Shield KD, Schwarzinger M.

Alzheimers Res Ther. 2019 Jan 5;11(1):1. doi: 10.1186/s13195-018-0453-0. Review.

6.

Authors' reply.

Schwarzinger M, Dufouil C, Rehm J.

Lancet Public Health. 2018 May;3(5):e217. doi: 10.1016/S2468-2667(18)30074-4. No abstract available.

7.

Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study.

Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J; QalyDays Study Group.

Lancet Public Health. 2018 Mar;3(3):e124-e132. doi: 10.1016/S2468-2667(18)30022-7. Epub 2018 Feb 21.

8.

Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France.

N'Diaye DS, Launay O, Picone O, Tsatsaris V, Azria E, Rozenberg F, Schwarzinger M, Yazdanpanah Y.

Vaccine. 2018 Feb 28;36(10):1285-1296. doi: 10.1016/j.vaccine.2018.01.042. Epub 2018 Feb 1.

PMID:
29397227
9.

"Who killed JR": Chronic hepatitis C or alcohol use disorders?

Schwarzinger M, Rehm J, Mallet V.

J Hepatol. 2018 May;68(5):1098-1099. doi: 10.1016/j.jhep.2017.11.042. Epub 2017 Dec 30. No abstract available.

PMID:
29294316
10.

Alcohol use disorders and associated chronic disease - a national retrospective cohort study from France.

Schwarzinger M, Thiébaut SP, Baillot S, Mallet V, Rehm J.

BMC Public Health. 2017 Jul 21;18(1):43. doi: 10.1186/s12889-017-4587-y. Erratum in: BMC Public Health. 2017 Sep 22;17 (1):736.

11.

Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study.

Kirchgesner J, Beaugerie L, Carrat F, Andersen NN, Jess T, Schwarzinger M; BERENICE study group.

Gut. 2018 Jul;67(7):1261-1268. doi: 10.1136/gutjnl-2017-314015. Epub 2017 Jun 24.

PMID:
28647686
12.

Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study.

Schwarzinger M, Baillot S, Yazdanpanah Y, Rehm J, Mallet V.

J Hepatol. 2017 Sep;67(3):454-461. doi: 10.1016/j.jhep.2017.03.031. Epub 2017 Apr 8.

13.

Erratum to "Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study".

Mallet V, Hamed K, Schwarzinger M.

J Hepatol. 2017 May;66(5):1104. doi: 10.1016/j.jhep.2017.02.016. Epub 2017 Mar 9. No abstract available.

PMID:
28284450
14.

Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study.

Mallet V, Hamed K, Schwarzinger M.

J Hepatol. 2017 Mar;66(3):514-520. doi: 10.1016/j.jhep.2016.10.031. Epub 2016 Nov 5. Erratum in: J Hepatol. 2017 May;66(5):1104.

PMID:
27826056
15.

Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis.

Kirchgesner J, Beaugerie L, Carrat F, Sokol H, Cosnes J, Schwarzinger M; BERENICE Study Group.

PLoS One. 2016 Jun 6;11(6):e0157191. doi: 10.1371/journal.pone.0157191. eCollection 2016.

16.

Generic antiretroviral drugs and HIV care: An economic review.

Yazdanpanah Y, Schwarzinger M.

Med Mal Infect. 2016 Mar;46(2):67-71. doi: 10.1016/j.medmal.2016.01.003. Epub 2016 Feb 19. Review.

PMID:
26905394
17.

Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae.

Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger M, Andremont A, Lucet JC, Yazdanpanah Y.

Infect Control Hosp Epidemiol. 2016 Mar;37(3):272-80. doi: 10.1017/ice.2015.284. Epub 2015 Dec 28.

PMID:
26708383
18.

Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.

Fung M, Kim J, Marty FM, Schwarzinger M, Koo S.

PLoS One. 2015 Nov 10;10(11):e0140930. doi: 10.1371/journal.pone.0140930. eCollection 2015. Review.

19.

Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards.

El Maaroufi H, Goubard A, Redjoul R, Legrand P, Pautas C, Mikdame M, Doghmi K, Toma A, Maury S, Schwarzinger M, Cordonnier C.

Biomed Res Int. 2015;2015:945769. doi: 10.1155/2015/945769. Epub 2015 May 5.

20.

HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?

Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y.

Am J Obstet Gynecol. 2015 Sep;213(3):341.e1-12. doi: 10.1016/j.ajog.2015.05.010. Epub 2015 May 13.

PMID:
25979615

Supplemental Content

Loading ...
Support Center